Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.

Karin YamatakaPo-Sung ChuYuzo KodaNobuhito TanikiRei MorikawaAya YoshidaFumie NoguchiRyosuke KasugaTakaya TabuchiHirotoshi EbinumaTakanori KanaiNobuhiro Nakamoto

Published in: PloS one (2022)

Peri-treatment dynamics of serum 4COL7S, a non-invasive fibrosis marker, predict prognosis. Non-invasive fibrosis markers may be useful biomarkers for risk stratification post-SVR.

Keyphrases

hepatitis c virus
helicobacter pylori infection
human immunodeficiency virus
helicobacter pylori
antiretroviral therapy